We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$480M
AUM Growth
+$96.7M
(+25%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
645
New
258
Increased
78
Reduced
78
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Church & Dwight Co
CHD
$24.4B
| $315K | 0.07% |
+3,566
| New | +$298K |
|
327
Texas Roadhouse
TXRH
$13.8B
| $314K | 0.07% |
+2,903
| New | +$297K |
|
|
328
Advanced Micro Devices
AMD
$797B
| $308K | 0.06% |
3,145
-71,745
| -96% | -$5.84M |
|
329
Henry Schein
HSIC
$10.1B
| $306K | 0.06% |
+3,755
| New | +$306K |
|
330
Madrigal Pharmaceuticals
MDGL
$11.8B
| $306K | 0.06% |
+1,262
| New | +$344K |
|
331
Ormat Technologies
ORA
$6.05B
| $305K | 0.06% |
+3,595
| New | +$315K |
|
332
Unum
UNM
$14.1B
| $303K | 0.06% |
7,652
+1,735
| +29% | +$71.7K |
|
|
GOOS
333
Canada Goose Holdings
GOOS
$882M
| $303K | 0.06% |
+15,721
| New | +$311K |
|
334
W.R. Berkley
WRB
$26.6B
| $300K | 0.06% |
+7,228
| New | +$323K |
|
|
GRMN
335
Garmin
GRMN
$58.5B
| $300K | 0.06% |
+2,970
| New | +$290K |
|
|
HES
336
DELISTED
Hess
HES
| $296K | 0.06% |
+2,239
| New | +$312K |
|
337
Bloom Energy
BE
$69.1B
| $296K | 0.06% |
14,863
-22,044
| -60% | -$483K |
|
338
Primerica
PRI
$9.91B
| $295K | 0.06% |
+1,710
| New | +$280K |
|
339
Sibanye-Stillwater
SBSW
$7B
| $293K | 0.06% |
+35,206
| New | +$342K |
|
340
Pan American Silver
PAAS
$20.3B
| $288K | 0.06% |
+15,830
| New | +$272K |
|
|
RVNC
341
DELISTED
Revance Therapeutics, Inc.
RVNC
| $287K | 0.06% |
+8,909
| New | +$278K |
|
342
Kinder Morgan
KMI
$69.3B
| $282K | 0.06% |
+16,088
| New | +$286K |
|
343
Cactus
WHD
$5.3B
| $281K | 0.06% |
+6,811
| New | +$329K |
|
344
Oneok
OKE
$54.8B
| $277K | 0.06% |
4,356
-28,954
| -87% | -$1.92M |
|
345
B&G Foods
BGS
$287M
| $276K | 0.06% |
+17,786
| New | +$248K |
|
346
Elastic
ESTC
$7.33B
| $276K | 0.06% |
+4,759
| New | +$271K |
|
347
TripAdvisor
TRIP
$1.62B
| $275K | 0.06% |
+13,858
| New | +$296K |
|
348
Freshworks
FRSH
$3.23B
| $274K | 0.06% |
+17,838
| New | +$270K |
|
349
Ulta Beauty
ULTA
$23.2B
| $272K | 0.06% |
+498
| New | +$256K |
|
350
D.R. Horton
DHI
$42.4B
| $271K | 0.06% |
+2,771
| New | +$264K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.